Publications by authors named "Fernando Labella Alvarez"

Claim this Profile
O
Optic nerve sheath enhancement in patients with a new diagnosis of idiopathic intracranial hypertension.
Fernando Labella Álvarez, Amit M Saindane, Valérie Biousse, Nancy J Newman

Front Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trial.
Michael Lowe, Gabriele Berman, Fernando Labella Álvarez, Alex Sinclair, Susan P Mollan

Eye (Lond)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial.
Sam Sherratt-Mayhew, Charles Page, Michael Lowe, Fernando Labella Alvarez, Susan P Mollan

Eye (Lond)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying the 2022 optic neuritis criteria to noninflammatory optic neuropathies with optic nerve T2-hyperintensity: an observational study.
Fernando Labella Álvarez, Valérie Biousse, Rasha Mosleh, Amit M Saindane, Nancy J Newman

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glaucoma as a cause of optic nerve abnormalities on magnetic resonance imaging.
Rasha Mosleh, Fernando Labella Álvarez, Walid Bouthour, Amit M Saindane, Michael Dattilo

Eye (Lond)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optic Nerve MRI T2-Hyperintensity: A Nonspecific Marker of Optic Nerve Damage.
Fernando Labella Álvarez, Rasha Mosleh, Walid Bouthour, Amit M Saindane, Beau B Bruce

J Neuroophthalmol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis